FDA Approves TRAMADOL HYDROCHLORIDE — Amneal Pharmaceuticals NY LLC
Amneal Pharmaceuticals NY LLC announced the approval of its ANDA for tramadol hydrochloride oral tablet from the FDA, initiating commercialization of generic equivalents to the pai…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Amneal Pharmaceuticals NY LLC announced the approval of its ANDA for tramadol hydrochloride oral tablet from the FDA, initiating commercialization of generic equivalents to the pai…
Teva Pharmaceuticals USA, Inc. received FDA approval for generic Tramadol Hydrochloride tablets, a development likely to intensify generic competition and pressure pricing within t…
# FDA Approves Roerig's VFEND (voriconazole) for Invasive Fungal Infections Roerig has received FDA approval for VFEND (voriconazole), an oral antifungal agent designed to treat s…
PHARMOBEDIENT received FDA approval for its ANDA on April 22, 2002, position the company to capture market share and increase competition within the relevant therapeutic segment.
Hikma Pharmaceuticals USA Inc. secured FDA approval for its generic nasal butorphanol tartrate product, reinforcing its strategic expansion within the pain management sector. This …
Lannett Company, Inc. leverages the regulatory milestone for its oral levothyroxine sodium formulation to secure a consistent market footprint in the generic thyroid hormone replac…
Watson Pharmaceuticals (now Actavis) received final approval from the U.S. FDA for Abbreviated New Drug Application (ANDA) 075961 on January 25, 2002. This clearance positions the …
# FDA Approves VABRINTY (Leuprolide Acetate) for Subcutaneous Administration Uronova Pharmaceuticals, Inc. received FDA approval for VABRINTY (leuprolide acetate) injection, expan…
Aurobindo Pharma USA has secured FDA approval to market a generic drug with ANDA 076152, moving the company to fulfill a specific market need. This regulatory milestone enhances Au…
LGM Pharma Solutions, LLC (LGM) obtained FDA approval today for ORAL Ascomp with Codeine tablets (generic butalbital, aspirin, caffeine, and codeine phosphate), a combination analg…
# FDA Approves Amphetamine Combination Formulation for Prasco Laboratories Prasco Laboratories received FDA approval for its oral amphetamine combination therapy on October 11, 20…
Kenvue Brands LLC secured a competitive edge in the oral allergy market with the 2001 FDA approval of ZYRTEC-D, allowing the company to leverage a branded combination of cetirizine…
RISING announced today that the FDA has approved its ANDA, a regulatory milestone that the company expects will bolster its financial performance and generate near-term revenue gro…
# FDA Approves Teva Women's Health's Oral Methotrexate Sodium Product Teva Women's Health LLC received FDA approval for TREXALL (methotrexate sodium) oral formulation, expanding t…
On December 19, 2000, Rising received FDA approval for ANDA075725, marking a significant commercial entry into the market. This approval is expected to bolster the company’s revenu…
# FDA Approves Doxycycline ANDA for Strides Pharma Science Limited Strides Pharma Science Limited has received FDA approval for its abbreviated new drug application (ANDA065055) f…
# FDA Approval Newswire Kenvue Brands LLC has received FDA approval for IMODIUM Multi-Symptom Relief, an oral combination formulation of loperamide hydrochloride and dimethicone, …
# FDA Approves Fresenius Medical Care's Venofer for Intravenous Iron Supplementation Fresenius Medical Care Holdings, Inc. received FDA approval for Venofer (iron sucrose), an int…
# FDA Approves Generic Leuprolide Acetate for Meitheal Pharmaceuticals Meitheal Pharmaceuticals Inc received FDA approval for its generic leuprolide acetate injection (ANDA075471)…
Advagen Pharma Ltd obtained FDA approval on October 6, 2000, for its generic oral Clonazepam tablet under ANDA075468. The clearance is expected to bolster Advagen’s earnings potent…